Welcome

 

Our research is focused on the transcriptional pathways that underlie metabolic diseases like obesity and Type 2 diabetes. In particular, we have a longstanding interest in using genomic and epigenomic approaches to identify novel transcription factors and pathways that regulate processes such as adipogenesis, lipid handling, insulin resistance, and metabolic memory. Our ultimate goal is to define novel targets that can be manipulated to improve outcomes in metabolic disease.

  • Farewell to Greg Westcott & Winnie Zhang

    The Rosen Lab is bidding a fond farewell to Greg Westcott and Winnie Zhang as 2025 draws to a close.

    Greg’s leadership has been instrumental in advancing our knowledge on lymphedema, while Winnie’s tenacity have been the driving force in bringing the IRS1 project to a successful completion. It has been a privilege to work alongside them. As they move into the industry sector, we know they will continue to do great things. We wish you the very best!

  • Rosen Lab reveals new insights into adipose tissue adaptation to weight loss in mice

    Please check out the new paper from the Rosen lab (working in collaboration with Randy Seeley’s group at the University of Michigan) about changes in adipose tissue after two different weight loss strategies in mice. Margo Emont compared white adipose tissue from obese mice that received either vertical sleeve gastrectomy (VSG) or semaglutide. Some important changes in gene expression and cellular composition were conserved across weight loss interventions, while others were specific to either semaglutide or VSG. Margo also found that some gene expression programs in adipocytes reverted to a chow-like state after weight loss, while others remained “locked” in the obese pattern. link

  • Welcome, Anne!

    We are excited to welcome Anne Goergen to the Rosen Lab. Anne joins us from the University of Zurich, where she investigated the role of cellular stress responses in liver and their impact on body weight regulation. Welcome, Anne!